Skip to main content
. 2019 Jul 3;6(2):e001048. doi: 10.1136/openhrt-2019-001048

Figure 3.

Figure 3

The clinical use of Bioactive adrenomedullin (bio-ADM) and proenkephalin A 119–159 (penKid) for management of heart failure.